Midazolam maleate does have a short (two-hour) half-life verified by this steady state study in volunteers. This short duration of action, coupled with its pharmacologic profile and water solubility make midazolam maleate a promising agent for anesthesia use.
|Original language||English (US)|
|Issue number||3 SUPPL|
|State||Published - Jan 1 1979|
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine